Mikashmi Kohli
@MikashmiKohli
Followers
712
Following
2K
Media
159
Statuses
933
Scientific officer @FIND. Member of @tb_pai group. Passionate about TB and infectious diseases and bringing about a change!
Geneva, Switzerland
Joined March 2014
๐ ๐ผ๐น๐ฏ๐ถ๐ผ ๐ถ๐ ๐ป๐ผ๐ ๐๐ก๐ฉ๐๐ฆ๐ ๐๐ ๐ฃ (๐๐ผ๐ผ๐ฑ ๐ ๐ฎ๐ป๐๐ณ๐ฎ๐ฐ๐๐๐ฟ๐ถ๐ป๐ด ๐ฃ๐ฟ๐ฎ๐ฐ๐๐ถ๐ฐ๐ฒ๐) ๐ฐ๐ฒ๐ฟ๐๐ถ๐ณ๐ถ๐ฒ๐ฑ. Yet another humbling milestone that reinforces our presence in Brazil โ affirming that Truenatโs real-time PCR tests are manufactured in accordance with the
0
2
6
Back on course after lunch at @G20SouthAfrica #HWG. Session is, โAccess to Medical Countermeasuresโ and opened with a keynote by @RVMCollabโs managing director, @frekris. Followed by a panel discussion to be moderated by @FINDdx Board Member, Prof. Precious Matsoso.
0
3
6
In the space of growing #tb innovations and #ai tools, rapid and robust evidence is needed to move policy. Updated policy on #cad for tb screening. An important milestone in the space of artificial intelligence and digital health innovations @FINDdx @WHO
@WHO has recently published its policy statement on the use of computer-aided detection software for tuberculosis screening - https://t.co/WLYqQBWcxc
@FINDdx led this evidence generation for policy and the number of products recommended have increased significantly (from 3
0
0
4
Moving the dial on diagnostics: an update from the Lancet Commission o... https://t.co/qaYQrBBVG1 co-authored by @FINDdx colleagues - @MikashmiKohli and Kekeletso Kao.
0
2
4
We are excited to announce the new publication of a study in @TropicalmedMDPI, co-authored by Vanessa Fargnoli, @MikashmiKohli, Kavindhran Velen, and Sonjelle Shilton from our impact and TB teams. https://t.co/V8UgLlHSwR
mdpi.com
Inadequate access to timely diagnosis and linkage to treatment are major barriers to tuberculosis (TB) care. New point-of-care diagnostics that do not rely solely on sputum samples are needed to make...
1
1
3
Today WHO released Guidance on evidence generation (GEG) on new regimens for #TB treatment โ a first-of-its-kind document that advises researchers, developers, funders, and other stakeholders about how evidence should be generated to optimally inform WHO guideline development.
1
12
19
New guidance document on clinical trials just published by WHO. Strongly encourage anyone working on clinical trials to read this document https://t.co/Py7hop6SjA
1
8
10
If you are in Geneva, do not miss this event! Use of Digital technologies and still maintaining your physical, mental and emotional well being! #digitalwellbeing
0
1
5
Thank you to everybody who helped make this consensus article what it is, and advance our thinking on it @TobiBorger1
@ruvandhi
@paimadhu
@acattamanchi
@davidwdowdy
@ankurgw
@MikashmiKohli
1
1
3
๐
Don't miss the roundtable discussion on June 11 where we'll dive into achieving gender equity in research. Gain practical guidance on implementing the SAGER guidelines. #GenderEquity #ResearchDiscussion Register now to be part of the conversation: https://t.co/6FFdrD9C2i
researcheracademy.elsevier.com
Researcher Academy and GENDRO are excited to invite you to watch a recorded roundtable discussion on Sex and Gender Equity in Research (SAGER). The SAGER Guidelines are a comprehensive procedure for...
0
2
2
We are pleased to strengthen @WHO-@FINDdx collaboration with a new Memorandum of Understanding, as we mark the first anniversary since the global resolution on diagnostics, and we are ramping up our efforts to tackle #AntimicrobialResistance. #WHA77
On the side-lines of #WHA77, honored & delighted to formalise a Memorandum of Understanding between @WHO and @FINDdx. In @DrTedros' words: โIt is much more than a formalization of our collaboration, as it opens new avenues to jointly work together, save lives and improve health.โ
49
47
116
Dietary Guidelines for Indians. National Institute of Nutrition @ICMRDELHI @ICMRNIN 2024 https://t.co/O7qJ84g7m3
5
41
96
Work Package Biomarkers of @UNITE4TB has developed two target product profiles for biomarker-based treatment monitoring tools suitable for phase 2 and 3 clinical drug trials. https://t.co/Tu8XvLHcph
0
1
6
Thank you for being an amazing mentor @paimadhu! We would not have been here without your guidance and support!
0
1
29
ICE-TB framework is out! Redefining the early TB states and its non-linearity! @FINDdx @hanifesmail_tb @ucl @WEHI_research
Our new ICE-TB framework recognises the importance of Subclinical TB diagnosis & treatment to improve outcomes and reduce TB transmission. Huge thanks to >70 involved @hanifesmail_tb @Rein_Houben @JamesSeddon10 @DrAsadZaidi @digby_warner @Tamarakredo
https://t.co/4hKlZWzQof
1
2
10
Thank you for your leadership and inspiring us all to do better! #YesWeCanEndTB
0
0
5
After TB disease spectrum, our new paper in the โฆ@LancetRespirMedโฉ now focuses on early TB states to guide new research and innovation. โฆ@FINDdxโฉ โฆ@UCT_newsโฉ โฆ@uclโฉ โฆ@WEHI_researchโฉ โฆ@LSHTMโฉ #WorldTBDay
thelancet.com
The current activeโlatent paradigm of tuberculosis largely neglects the documented spectrum of disease. Inconsistency with regard to definitions, terminology, and diagnostic criteria for different...
0
2
6